PCOS: a modern fertility strategy
Insulin, ovulation, weight, inositol, letrozole — what actually moves the needle for PCOS patients trying to conceive.
- 01
PCOS is a spectrum — not one disease, not one treatment.
- 02
Letrozole has overtaken Clomid as the first-line ovulation induction agent.
- 03
Inositol has real evidence behind it; not all supplements do.
- 04
Even modest weight changes can meaningfully restore ovulation.
PCOS is one of the most misunderstood diagnoses in reproductive medicine. It's a spectrum. Two patients with the same diagnosis can have completely different bodies, completely different challenges, and completely different paths forward.
The throughline for most patients is insulin resistance. Addressing that — sometimes with metformin, sometimes with inositol, almost always with lifestyle work — opens the door to ovulation in a way no medication alone can.
Letrozole is now the first-line ovulation induction medication for PCOS. The data is clear. Higher live birth rates than Clomid, fewer multiples, and better tolerated.
Transcript edited for clarity. The audio is the authoritative source.
Subscribe to the podcast
Liked "PCOS: a modern fertility strategy"? Get the next episode as soon as it drops.
Book a private consultation
Bring your questions from the episode to a one-on-one conversation with Dr. Ghadir. Discuss your goals, options, and a plan that fits you.
